Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.5.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.5.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.5.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.59ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.59ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.59EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.59EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.15ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.15ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.15EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.503ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.503ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.31EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.31ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.31ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.31EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.31EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.623EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.623EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.623ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.623ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.623EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.623EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.623ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.623ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.214.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.214.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.214.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.214.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used